+499.5%
MRNA vs LEN
-37.1%
+536.6%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | LEN | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.0% | -1.2% | -1.5% |
| 7D | +5.5% | -3.2% | +8.7% | +7.8% |
| 30D | +158.7% | -4.9% | +163.6% | +168.6% |
| 3M | +182.1% | -8.5% | +190.6% | +195.7% |
| 6M | +151.8% | -20.7% | +172.5% | +173.7% |
| YTD | +393.6% | -17.4% | +411.0% | +425.2% |
| 1Y | +499.5% | -38.2% | +537.7% | +619.7% |
| All | +499.5% | -37.1% | +536.6% | +619.7% |
Cumulative growth
Daily Returns
Daily percentage return beside LEN.
Daily Out/Under-Performance
Portfolio return minus LEN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × LEN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded LEN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling